Notice2021-28343
Tiered Pharmacy Copayments for Medications; Calendar Year 2022 Update
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
December 30, 2021
Issuing agencies
Veterans Affairs Department
Abstract
This Department of Veterans Affairs (VA) notice updates the information on Tier 1 medications.
Full Text
<html>
<head>
<title>Federal Register, Volume 86 Issue 248 (Thursday, December 30, 2021)</title>
</head>
<body><pre>
[Federal Register Volume 86, Number 248 (Thursday, December 30, 2021)]
[Notices]
[Pages 74431-74432]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2021-28343]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF VETERANS AFFAIRS
Tiered Pharmacy Copayments for Medications; Calendar Year 2022
Update
AGENCY: Department of Veterans Affairs.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: This Department of Veterans Affairs (VA) notice updates the
information on Tier 1 medications.
FOR FURTHER INFORMATION CONTACT: Mr. Joseph Duran, Director of Policy
and Planning, Office of Community Care (13BOA1), Veterans Health
Administration, 3773 Cherry Creek North Drive, Denver, CO 80209, 303-
370-1637. This is not a toll-free telephone number.
SUPPLEMENTARY INFORMATION: Section 17.110 of title 38, CFR, governs
copayments for medications that VA provides to Veterans. Section 17.110
provides the methodologies for establishing the copayment amount for
each 30-day or fewer supply of medication provided by VA on an
outpatient basis (other than medication administered during treatment).
Tier 1 medication means a multi-source medication that has been
identified using the process described in paragraph (b)(2) of this
section. Not less than once per year, VA will identify a subset of
multi-source medications as Tier 1 medications. Only medications that
meet all of the criteria in 38 CFR 17.110(b)(2)(i), (ii) and (iii) will
be eligible to be considered Tier 1 medications, and only those
medications that meet all of the criteria in paragraph (b)(2)(i) of
this section will be assessed using the criteria in paragraphs
(b)(2)(ii) and (iii).
Based on the methodologies set forth in Sec. 17.110, this notice
updates the list of Tier 1 medications for Calendar Year 2022. The Tier
1 medication list is posted on VA's Community Care website at the
following link: <a href="https://www.va.gov/COMMUNITYCARE/revenue_ops/copays.asp">https://www.va.gov/COMMUNITYCARE/revenue_ops/copays.asp</a>
under the heading ``Tier 1 Copay Medication List.''
The following table is the Tier 1 Copay Medication List that is
effective January 1, 2022, and will remain in effect until December 31,
2022.
------------------------------------------------------------------------
Condition VA product name
------------------------------------------------------------------------
Arthritis and Pain................ Aspirin Buffered Tablet.
Aspirin Chewable Tablet.
Aspirin Enteric-Coated (EC) Tablet.
Allopurinol Tablet.
Celecoxib Capsule.
Diclofenac Tablet.
Ibuprofen Tablet.
Meloxicam Tablet.
Naproxen Tablet.
Blood Thinners and................ Clopidogrel Bisulfate Tablet.
Platelet Inhibitors............... Warfarin Sodium Tablet.
Cholesterol....................... Atorvastatin Tablet.
Ezetimibe Tablet.
Pravastatin Tablet.
Rosuvastatin Calcium tablet.
Simvastatin Tablet.
Dementia.......................... Donepezil Tablet.
Diabetes.......................... Glimepiride Tablet.
Glipizide Tablet.
Metformin Hydrochloride (HCL)
Tablet.
Metformin HCL 24-Hour Sustained
Action (SA) Tablet.
Pioglitazone HCL Tablet.
Electrolyte Supplement............ Potassium SA Tablet.
Potassium SA Dispersible Tablet.
Gastrointestinal Health........... Famotidine Tablet.
Omeprazole EC Capsule.
Pantoprazole Sodium EC Capsule.
Psyllium Mucilloid.
Glaucoma and Eye Care............. Diclofenac Solution.
Dorzolamide 2%/Timolol 0.5%
Solution.
Latanoprost 0.005% Solution.
Carboxymethylcellulose Sodium
Solution.
Heart Health and Blood Pressure... Amlodipine Tablet. Aspirin (see
Arthritis & Pain).
Atenolol Tablet.
Carvedilol Tablet.
Chlorthalidone Tablet.
Clonidine Tablet.
Digoxin Tablet.
Diltiazem 24-Hour Capsule.
Diltiazem HCL Tablet.
[[Page 74432]]
Furosemide Tablet.
Hydralazine HCL Tablet.
Hydrochlorothiazide Tablet/Capsule.
Hydrochlorothiazide/Lisinopril
Tablet.
Hydrochlorothiazide/Losartan Tablet.
Hydrochlorothiazide/Triamterene
Tablet/Capsule.
Isosorbide Mononitrate SA Tablet.
Lisinopril Tablet.
Losartan Tablet.
Metoprolol Succinate SA Tablet.
Metoprolol Tartrate Tablet.
Nifedipine SA Capsule.
Nitroglycerin Sublingual Tablet.
Prazosin HCL Capsule.
Propranolol HCL Tablet.
Spironolactone Tablet.
Mental Health..................... Amitriptyline HCL Tablet.
Buspirone HCL Tablet.
Bupropion HCL Tablet.
Bupropion HCL SA (12-HR-SR) Tablet.
Bupropion HCL SA (24-HR-XL) Tablet.
Citalopram Hydrobromide Tablet.
Duloxetine HCL EC Capsule.
Escitalopram Oxalate Tablet.
Fluoxetine Tablet/Capsule.
Mirtazapine Tablet.
Olanzapine Immediate Release (IR)
Tablet.
Paroxetine Tablet.
Sertraline HCL Tablet.
Trazodone Tablet.
Venlafaxine HCL IR Tablet.
Venlafaxine HCL SA Capsule.
Neurologic Disorders.............. Ropinirole IR Tablet.
Respiratory Condition............. Montelukast Sodium Tablet.
Seizures.......................... Gabapentin Capsule.
Lamotrigine Tablet.
Topiramate Tablet.
Thyroid Conditions................ Levothyroxine Sodium Tablet.
Urologic (Bladder and Prostate) Doxazosin Mesylate Tablet.
Health. Finasteride Tablet.
Oxybutynin Chloride IR tablet.
Oxybutynin Chloride SA tablet.
Sildenafil Tablet.
Tadalafil Tablet.
Tamsulosin HCL Capsule.
Terazosin HCL Capsule.
------------------------------------------------------------------------
Signing Authority
The Secretary of Veterans Affairs, approved this document on
December 14, 2021, and authorized the undersigned to sign and submit
the document to the Office of the Federal Register for publication
electronically as an official document of the Department of Veterans
Affairs.
Jeffrey M. Martin,
Assistant Director, Office of Regulation Policy & Management, Office of
General Counsel, Department of Veterans Affairs.
[FR Doc. 2021-28343 Filed 12-29-21; 8:45 am]
BILLING CODE 8320-01-P366
</pre></body>
</html>Indexed from Federal Register on December 30, 2021.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.